Artemisinin and a series of novel endoperoxide antimalarials exert early effects on digestive vacuole morphology.
Artermisinin and its derivatives are now the mainstays of antimalarial treatment; however, their mechanism of action is only poorly understood. We report on the synthesis of a novel series of epoxy-endoperoxides that can be prepared in high yields from simple starting materials. Endoperoxides that are disubstituted with alkyl or benzyl side chains show efficient inhibition of the growth of both chloroquine-sensitive and -resistant strains of Plasmodium falciparum. A trans-epoxide with respect to the peroxide linkage increases the activity compared to that of its cis-epoxy counterpart or the parent endoperoxide. The novel endoperoxides do not show a strong interaction with artemisinin. We have compared the mechanism of action of the novel endoperoxides with that of artemisinin. Electron microscopy reveals that the novel endoperoxides cause the early accumulation of endocytic vesicles, while artemisinin causes the disruption of the digestive vacuole membrane. At longer incubation times artemisinin causes extensive loss of organellar structures, while the novel endoperoxides cause myelin body formation as well as the accumulation of endocytic vesicles. An early event following endoperoxide treatment is the redistribution of the pH-sensitive probe LysoSensor Blue from the digestive vacuole to punctate structures. By contrast, neither artemisinin nor the novel endoperoxides caused alterations in the morphology of the endoplasmic reticulum nor showed antagonistic antimalarial activity when they were used with thapsigargin. Analysis of rhodamine 123 uptake by P. falciparum suggests that disruption of the mitochondrial membrane potential occurs as a downstream effect rather than as an initiator of parasite killing. The data suggest that the digestive vacuole is an important initial site of endoperoxide antimalarial activity.
del Pilar Crespo
Maria
M
Department of Biochemistry, La Trobe University, Plent Rd., Melbourne, 3086 Victoria, Australia.
Avery
Thomas D
TD
Hanssen
Eric
E
Fox
Emma
E
Robinson
Tony V
TV
Valente
Peter
P
Taylor
Dennis K
DK
Tilley
Leann
L
D000818:Animals; D000962:Antimalarials / Q000737:chemistry / Q000494:pharmacology*; D037621:Artemisinins / Q000494:pharmacology*; D004347:Drug Interactions; D004721:Endoplasmic Reticulum / Q000187:drug effects / Q000648:ultrastructure; D006801:Humans; D020128:Inhibitory Concentration 50; D008928:Mitochondria / Q000187:drug effects / Q000648:ultrastructure; D021261:Parasitic Sensitivity Tests; D010545:Peroxides / Q000138:chemical synthesis / Q000737:chemistry / Q000494:pharmacology*; D010963:Plasmodium falciparum / Q000187:drug effects* / Q000254:growth & development / Q000648:ultrastructure; D013997:Time Factors; D014617:Vacuoles / Q000187:drug effects* / Q000648:ultrastructure*
D000962:Antimalarials; D037621:Artemisinins; D010545:Peroxides; C031327:artemisinin